Pricing Log in Create free account
Saturday 17 October 2026 Export UHS’s income statement to Excel — free account

Universal Health Services, Inc.

UHS Healthcare Medical Care Facilities

Universal Health Services, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $17.4 billion, up 9.71% from fiscal 2024. In the quarter to June 2026, revenue grew 8.27%, EPS grew 9.47%, free cash flow fell 23.8% and total debt rose 5.87%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten.

185.10 2.26 −1.21%
Market cap
$11.0B
P/E
7.5×
Fwd P/E
6.1×
Dividend yield
0.43%
F-score
8/9
Altman Z
3.29
Beneish M
−2.45
Dividend safety
88/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Universal Health Services, Inc. (UHS) EV/EBITDA

Alert me on EV/EBITDA

As of 16 October 2026, Universal Health Services, Inc. (UHS) trades at a EV/EBITDA of 5.8×. Over the past ten years it has ranged from 4.9× (July 2026) to 11.5× (June 2015); the current reading is higher than 4% of that period. That is below the Medical Care Facilities industry median of 10.2× and below the Healthcare sector median of 9.2×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 7.1× (1.78%)
FY2024 7.2× (19.72%)
FY2023 9.0× (6.04%)
FY2022 9.5× 22.51%
FY2021 7.8× 1.62%
FY2020 7.7× (21.46%)
FY2019 9.8× 7.65%
FY2018 9.1× 4.31%
FY2017 8.7× 1.98%
FY2016 8.5× (6.86%)

Quarterly newest first

Period EV/EBITDA Change
Jun 2026 5.0× (13.50%)
Mar 2026 5.8× (17.74%)
Dec 2025 7.1× 3.38%
Sep 2025 6.8× 2.30%
42 more quarters

Against its own ten years

Low 4.9× High 11.5×
Ten-year median 8.6×
Current reading's percentile 4

EV/EBITDA against peers

Company EV/EBITDA
FMS Fresenius Medical Care AG & Co. KGaA compare 4.9×
UHS Universal Health Services, Inc. 5.8×
THC Tenet Healthcare Corporation compare 6.1×
DVA DaVita Inc. compare 7.8×
EHC Encompass Health Corporation compare 10.3×
CON Concentra Group Holdings Parent, Inc. compare 13.6×
PACS PACS Group, Inc. compare 15.6×
CHE Chemed Corporation compare 16.5×
ENSG The Ensign Group, Inc. compare 17.2×
Medical Care Facilities industry median 10.2×
Healthcare sector median 9.2×
Market median 11.0×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on UHS